Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

被引：0
|
作者：
Font, A
Esteban, E
Carles, J
Climent, MA
Gonzalez-Larriba, JL
Berrocal, A
Bellmunt, J
Garcia-Ribas, I
Marfa, X
Fabregat, X
机构：
[1] Hosp Germans Trias & Pujol, Badalona, Spain
[2] Hosp Gen Asturias, E-33006 Oviedo, Spain
[3] Hosp Mar, Barcelona, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Gen Hosp, Valencia, Spain
[7] Hosp Gen Valle Hebron, Barcelona, Spain
[8] Eli Lilly & Co, Alcobendas, Spain
[9] Sanofi Sinthelabo, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4544
引用
收藏
页码：392S / 392S
页数：1
相关论文
共 50 条
  • [21] A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
    Chao, Yee
    Hsieh, Jan-Sing
    Yeh, Hsien-Tang
    Su, Yu-Chieh
    Wu, Cheng-Chung
    Chen, Jen-Shi
    Tai, Cheng-Jeng
    Bai, Li-Yuan
    Yeh, Kun-Huei
    Su, Wu-Chou
    Li, Chung-Pin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 799 - 806
  • [22] Phase II trial of S-1 in combination with gemcitabine in chemo-naive patients with locally advanced or metastatic pancreatic cancer
    Lee, G.
    Kim, H.
    Kang, M.
    Kim, T.
    Kim, H.
    Kang, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] MRG002-006: A multicenter phase II clinical trial of MRG002-ADC for unresectable locally advanced or metastatic urothelial cancer.
    Qu, Wang
    Fu, Cheng
    Han, Weiqing
    Sun, Yongkun
    Quan, Jizhong
    Chen, Lijun
    Luo, Hong
    Hu, Hailong
    Niu, Yinong
    Xu, Danfeng
    Liao, Yong
    Chen, Minfeng
    Hu, Changlu
    Liu, Yongda
    Chen, Jimin
    Liu, Lian
    Shi, Benkang
    Chen, Guojun
    Zhou, Fangjian
    Zhou, Ai-Ping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Phase II trial of goserelin and exemestane combination therapy in premenopausal women with locally advanced or metastatic breast cancer.
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Luo, Yang
    Cai, Ruigang
    Fan, Ying
    Li, Qiao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] A phase II randomized, placebo controlled study to evaluate the efficacy of the combination of gemcitabine, erlotinib, and metformin in patients with locally advanced or metastatic pancreatic cancer.
    Wilmink, Johanna
    Kordes, Sil
    Zwinderman, Koos
    Mathot, Ron
    Punt, Cornelis J. A.
    Richel, Dirk
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [27] Combination chemotherapy with docetaxel and gemcitabine in patients with metastatic or locally advanced pancreatic carcinoma:: Results of a multicenter phase II study.
    Fahlke, J
    Ridwelski, K
    Schmidt, C
    Stübs, P
    Weber, M
    Eichelmann, K
    Kettner, E
    Hribaschek, A
    Lippert, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 338S - 338S
  • [28] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metastatic or recurrent pancreatic cancer
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dongbok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [29] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metasetatic or recurrent pancreatic cancer.
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
12345